Efficacy of rechallenge with BRAF inhibition therapy in patients with advanced BRAFV600 mutant melanoma

ConclusionAlthough no comparative studies have been conducted, rechallenging with BRAF inhibition therapy seems a plausible treatment option. Randomized trials are needed to confirm these results.

Source: Clinical and Translational Oncology - January 3, 2019 Category: Cancer & Oncology Source Type: research